Curtin College analysis to develop an early analysis device predicting how most cancers sufferers will reply to chemotherapy has obtained a funding enhance of virtually half one million {dollars} via the Innovation Seed Fund 2023-24.
Led by Dr Yu Yu from Curtin Medical College and the Curtin Well being Innovation Analysis Institute, the venture seeks to create a diagnostic take a look at to establish sufferers who will profit from platinum-based chemotherapy, which is usually utilized in combatting superior cancers, however usually has poor outcomes.
Dr Yu mentioned ineffective remedy impacts as much as 1,500 folks in WA yearly and greater than two million globally. “Sadly, as much as half of all sufferers don’t reply to platinum-based chemotherapy and the objective of this venture is to supply clinicians with a device that precisely predicts responses utilizing biopsies on the onset of remedy,” Dr Yu mentioned.
“This diagnostic take a look at, generally known as ChemoDx, will improve medical decision-making, scale back pointless opposed results and probably enhance survival charges by paving the way in which for tailor-made first-line remedies.”
Curtin College Deputy Vice-Chancellor Analysis Professor Melinda Fitzgerald congratulated Dr Yu and her group on the profitable funding final result.
“This essential analysis addresses a vital hole in most cancers care and has the potential to rework most cancers remedy making an actual distinction to folks’s lives,” Professor Fitzgerald mentioned.
“Assist from the Innovation Seed Fund reinforces Curtin’s ongoing dedication to pioneering analysis that addresses vital well being points and permits our greatest minds to excel of their discipline.”
The venture, titled “Early Detection of Platinum-Chemotherapy Drug Response in Stable Tumour Biopsies”, focuses initially on ovarian most cancers, one of many deadliest cancers with a excessive incidence of drug resistance and late-stage analysis.
“Drug resistance is a major barrier to profitable most cancers remedy and the lack to foretell platinum resistance exposes sufferers to chemotherapy unwanted effects with out therapeutic profit and weakens the immune system,” Dr Yu mentioned.
“We have now recognized biomarkers that predict the response of ovarian most cancers to chemotherapy and the anticipated final result is the event of a diagnostic device that can enhance most cancers affected person remedy worldwide.”
The Innovation Seed Fund, funded via the Western Australian Future Well being Analysis and Innovation Fund, helps Western Australian innovators and early-stage start-up corporations to develop and commercialise cutting-edge well being and medical improvements.
